Classification of gadolinium-based contrast agents (GBCAs)-adverse reactions

Ingrid B Boehm

doi:10.1016/j.mri.2021.10.006

Classification of gadolinium-based contrast agents (GBCAs)-adverse reactions

Magn Reson Imaging. 2022 Jan:85:1-2. doi: 10.1016/j.mri.2021.10.006. Epub 2021 Oct 15.

Author

Ingrid B Boehm¹

Affiliation

¹ Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of Bern, Freiburgstrasse, 3010 Bern, Switzerland. Electronic address: ingrid.boehm@insel.ch.

PMID: 34662698
DOI: 10.1016/j.mri.2021.10.006

No abstract available

Keywords: Allergy; Gadolinium deposition disease; Gadolinium deposits; Gadolinium storage condition; Hypersensitivity reactions; Immediate reactions; Nephrogenic systemic fibrosis; Non-allergy; Non-immediate (delayed) reactions; Type A reactions; Type B reactions.

Publication types

Letter

MeSH terms

Contrast Media* / adverse effects
Gadolinium / adverse effects
Humans
Magnetic Resonance Imaging / adverse effects
Nephrogenic Fibrosing Dermopathy* / chemically induced

Substances

Contrast Media
Gadolinium